Characteristic | Overall (n=784) |
Age at randomisation, mean years±SD | 65.6±6.3 |
Male sex, n (%) | 458 (58.4) |
Race, n (%) | |
White | 537 (68.5) |
Black | 115 (14.7) |
Hispanic | 47 (6.0) |
Other | 85 (10.8) |
Highest level of education, n (%) | |
Some high school | 120 (15.3) |
High school graduate | 231 (29.5) |
Some college | 253 (32.3) |
College graduate or more | 180 (23.0) |
Clinical centre network, n (%) | |
Canada | 131 (16.7) |
Western | 100 (12.8) |
Minnesota/Iowa | 113 (14.4) |
Ohio/Michigan | 146 (18.6) |
Northeastern | 77 (9.8) |
Southeastern | 109 (13.9) |
Veterans affairs | 108 (13.8) |
Insurance coverage, n (%) | 715 (91.2) |
Smoking status, n (%) | |
Current | 66 (8.4) |
Former | 402 (51.3) |
Never | 316 (40.3) |
Cardiovascular disease, n (%) | 282 (36.0) |
HbA1C, mean %±SD | 8.3±1.0 |
Diabetes duration, mean years±SD | 16.3±8.0 |
Medications, n (%) | |
Oral hypoglycaemic agents | 628 (80.1) |
Insulin | 368 (46.9) |
Aspirin | 477 (60.8) |
Cardiovascular agents | 80 (10.2) |
Lipid-lowering agents | 563 (71.8) |
Bilateral cataract surgery, n (%) | 500 (63.8) |
HbA1C, haemoglobin A1C.